Aims: Nosocomial infection (NI) is one of the most important problems facing the world. This work is dedicated to investigating the prevalence rates of NI in addition to estimating the minimum inhibition concentration (MIC) of commercial antibiotics on isolated bacteria in order to determine the most diluted antibiotic that performed well with more efficiency and minimal toxicity . Place and Duration of Study: Gastroenterology Surgical Center, Mansoura University, Mansoura, Egypt, between July 2017 and July 2018. Methodology: This study included 368 different samples (urine, stool, sputum and surgical wounds) from 100 patients A total of 15 commercial antibiotics selected from seven families having different mode of action were used. Results: Our findings demonstrated that the highest prevalence rate of NI was detected in K. pneumoniae (40%, n=56) followed by MRSA (22.85%, n=32), E. coli (20%, n=28), P. mirabilis Abdel-Raouf et al.; SAJRM, 4(2): 1-8, 2019; Article no.SAJRM.50392 2 (7.85%, n=11), P. putida (5%, n=7) and finally P. aeruginosa (4.3%, n=6). In addition, the results showed variable MICs of various antibiotics on isolated bacteria associated with NI. Conclusion: Interestingly, our findings showed that quinolones family had the highest impact on all types of isolated bacteria associated with nosocomial infections.
INTRODUCTION
Nosocomial infection (NI) is considered to be the most difficult problems confronting clinicians who deal with severally ill patients. The incidence of NI is estimated at 5-10% in tertiary care hospitals reaching up to 28% in intensive care unit and 90% of these are caused by bacteria [1] . Generally, NIs can be defined as infection that were acquired during hospitalization by patients in whom the infection was not present or incubating at the time of admission [2, 3] , or any infections that were occurred within two days of hospital admission, three days of discharge or thirty days of an operation [4] . Indeed, NI could spread in the hospital and nursing home environments as well as clinic or other clinical settings. Interestingly, different routes for spreading NI to the susceptible patients in the clinical setting were reported. These routes include health care staff, contaminated equipment, bed linens and air droplets, etc [5] . NIs could also be originated from the outside environment, another infected patient, or the patient's own skin microbiota, becoming opportunistic after surgery or other procedures that compromise the protective skin barrier [6] . On the other hand, antibiotic treatment is more effective when started early, as well as when it is adapted to the sensitivity of the pathogens [7] . In this work, we are concerning with assessing the influence of different families of commercial antibiotics, that were diluted serially, on the isolated bacteria obtained from cultured patients' samples who have NIs in order to determine the extent to which the isolated bacteria could be affected. This in turn may give a clue to determine the most diluted antibiotic that performed well with more efficiency and minimal toxicity.
MATERIALS AND METHODS
One hundred consecutive patients staying three days or more were randomly recruited from the Gastroenterology Surgical Center (GEC), Mansoura University, Egypt. Different samples of urine, stool, sputum and surgical wound swabs were collected from patients for microbiological studies in order to identify nosocomial infection. Next, the obtained samples were cultured using nutrient agar in addition to MacConkey agar. The isolated bacteria were then morphologically and biochemically identified by VITEK 2 compact 15 (Biomerieux, France) and in turn kept for subsequent analysis for assessing the influence of different commercial antibiotics on them. Interestingly, different families of commercial antibiotics ( Table 1) were diluted serially from 10 -1 to 10 -5 . Next, a variety of cultured nutrient agar plates were then inoculated with 120 µL of each diluted antibiotic according to agar well-diffusion method [8] .
RESULTS AND DISCUSSION
No doubt, nosocomial infections are considered to be a serious public health issue. Of note, prevalence reports that were conducted in some developing countries have showed hospital-wide nosocomial infection rates mostly higher than 15% with a range from 6% to 27% [9] .
The first part of this work was concerned with identifying different bacterial isolates related to nosocomial infections and estimating their prevalence rates in different samples. Threehundred and sixty-eight samples were incorporated in this work. These samples were categorized into four different groups. They are urine (n=100), stool (n=100) and sputum (n=100) samples in addition to surgical wounds (n=68). These samples were further classified based on nosocomial infections into positive and negative groups as depicted in Fig. 1A . Overall, one hundred and forty (38%) samples were tested positive for the presence of nosocomial infections bacteria.
On the contrary, sputum samples were accompanied with the lowest positivity rate of 27% for nosocomial infections as shown in Fig.  1A lower than that reported previously by Custivic et al. [10] who showed that the nosocomial infections were detected in 60% in respiratory tract. On the contrary, our findings showed that 73.5% of surgical wounds, 28% of stool and 35% of urine samples were tested positive for the presence of nosocomial infections higher than that produced previously by Custivic et al. [10] who demonstrated that nosocomial infections were found in only 7%, 9% and 16% of surgical wounds, stool and urine samples, respectively.
It is noteworthy that nosocomial infections are caused by many microbes. However, bacteria are responsible for approximately 90% of nosocomial infections [11] . In this study, the agents that have been isolated from the included samples were K. pneumoniae, MRSA, E. coli, P. mirabilis, P. putida in addition to P. aeruginosa. Out of these bacteria, K. pneumoniae and MRSA were found to have the highest detection rates. The results showed that K. pneumoniae had a prevalence rate in urine, stool and surgical wounds accounting for 40%, 46.43% and 42%, respectively. On the other hand, MRSA infection displayed the highest detection rate in sputum samples (51.9%).
Custivic et al. [10] reported that most MRSA infections occurred in the respiratory tract whereas MRSA accounted for 18.4% of all respiratory tract isolates. He also showed that K. pneumoniae was the most common, associated with more than half of surgical wound infections. On the other hand, Shaikh et al. [12] reported E. coli as the most frequent pathogen (26.3%) while Klebsiella spp. was responsible for only 5.2% of all urinary tract infections.
Overall, our results indicate that 25%, 20%, 19.3% and 35.7% of total positive samples of NIs was detected in urine, stool, sputum and surgical wound swaps samples, respectively. Based on the appearance of isolated bacteria in different samples, samples of urine and surgical wounds swabs were found to be the best samples that could identify the bacterial nosocomial infections quickly. The positive samples were identified by VITEK 2 compact 15 (Biomerieux, France). As a consequence, different pathogenic bacteria were appeared with variable prevalence rates in different samples.
Overall, the present study showed that K. pneumoniae was found to have the highest detection rate of 40% (n=56) followed by MRSA (22.85%, n=32), E. coli (20%, n=28), P. mirabilis (7.85%, n=11), P. putida (5%, n=7) and finally P. aeruginosa (4.3%, n=6) as depicted in Fig. 1B . However, Borg et al. [13] reported that the highest levels of MRSA were observed in Jordan, Egypt and Malta, which were all above 50% higher than that provided in this study. Custivic et al. [10] reported that K. pneumoniae was the most frequently isolated gram negative pathogen (51% of all positive samples), followed by P. aeruginosa (10%), P. mirabilis (7%) and E. coli (4%), respectively; while MRSA was the most common among gram positive bacteria (15%).
The second part of this work was dedicated to investigating the influence of seven different families of commercial antibiotics on nosocomial infections. Thus, the efficiency of different families of commercial antibiotics in terms of minimum inhibition concentration (MIC) was then measured against the aforementioned bacteria associated with nosocomial infections and the results were summarized in Table 2 and Fig. 2 . 1 1x10 
Fig. 1. Different bacterial isolates associated with nosocomial infections (A) Prevalence rate of bacterial isolates in different patient samples, and (B) Types of isolated bacteria and their detection rate in different samples
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Fig. 2. Influence of some commercial antibiotics with different concentration on isolated bacteria associated with nosocomial infections (a) Amoxicillin on P. Aeruginosa, (b) Ampicillin on P. Mirabilis, (c) Amikacin on K. Pneumoniae, and (d) Neomycin on MRSA
The obtained MIC for quinolones were found to be the same in case of E. coli, MRSA, P. aeruginosa and P. mirabilis and the maximum antibiotic activity was found in levofloxacin followed by ciprofloxacin. The same goes for βlactam (MIC=10 -4 ) in case of E. coli, P. mirabilis, P. aeruginosa and P. mirabilis followed by MRSA (MIC=10 -2 ) and the maximum antibiotic activity was found in meropenem. The obtained MIC for aminoglycosides was found to be 10 -5 and 10 -4 in case of E. coli and P. aeruginosa, respectively, and the maximum antibiotic activity was found in amikacin (MIC=10 -5 ) with E. coli compared to other antibiotics. The obtained MIC for macrolides was found to be 10 -4 and 10 -2 in case of E. coli and MRSA, respectively. The obtained MIC for tetracycline was found to be 10 -4
in case of MRSA and 10 -2 in case of P. mirabilis and P. aeruginosa. Surprisingly, cephalosporin family showed no activity upon dilutions while its antibiotic activity was shown in case of its original form in K. pneumoniae, MRSA and P. mirabilis. Finally, the obtained MIC for glycopeptides was found to be 10 -3 in case of MRSA and 10 -1 in case of E. coli, P. aeruginosa and P. putida. Based on the aforementioned results, that quinolones family had the highest impact on all types of isolated bacteria associated with nosocomial infections.
Among these, the study that was reported by Lombardi et al. [14] who showed that P. putida was resistant to quinolones but it was susceptible to aminoglycosides except for amikacin. As well, Kim et al. [15] reported that P. Putida was susceptible to ciprofloxacin, levofloxacin, amikacin and meropenem. Another study was reported by Ayub et al. [16] showed that S. aureus and P. mirabilis were resistant to amoxicillin but susceptible to tetracycline. In addition, Mustafa et al. [17] reported that MRSA was resistant only to β-lactams while S. aureus was resistant to penicillin and susceptible to nitrofurantoin, vancomycin, levofloxacin, tetracycline, and erythromycin. Mustafa et al. [17] also reported that the most potent antimicrobials on E. coli were meropenem, levofloxacin and amikacin. It was also reported that K. Pneumoniae was susceptible to amikacin and moderately sensitive to ceftriaxone, ciprofloxacin and tetracycline. Additionally, Mustafa et al. [17] reported that the most potent antimicrobials on P. Aeruginosa were meropenem and levofloxacin while P. Aeruginosa was resistant to tetracycline, erythromycin and vancomycin. This is comparable with the rates reported by various authors Maehara et al. [ 
CONCLUSION
Our findings showed that quinolones family had the highest impact on all types of isolated bacteria associated with nosocomial infections.
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